SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Alimera Sciences, Inc.
(NASDAQ : ALIM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ALIM News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.18%81.371.2%$819.56m
AMGNAmgen Inc.
-0.47%174.801.1%$460.83m
BIIBBiogen Inc.
-0.71%312.581.0%$441.76m
MDVNMedivation, Inc.
0.42%81.421.9%$436.64m
SRPTSarepta Therapeutics, Inc.
-5.15%57.8330.9%$408.21m
CELGCelgene Corporation
-1.03%109.430.8%$405.97m
REGNRegeneron Pharmaceuticals, Inc.
0.58%410.393.2%$302.11m
CPHDCepheid
0.00%52.504.7%$200.30m
ALXNAlexion Pharmaceuticals, Inc.
-4.84%127.222.3%$175.19m
CLVSClovis Oncology, Inc.
-3.18%37.1425.5%$166.98m
ILMNIllumina, Inc.
-0.01%179.333.4%$137.85m
VRTXVertex Pharmaceuticals Incorporated
-1.62%90.632.2%$121.43m
BMRNBioMarin Pharmaceutical Inc.
-0.05%97.403.8%$118.10m
TSROTESARO, Inc.
0.15%108.5915.9%$116.58m
INCYIncyte Corporation
-0.33%88.982.7%$107.31m

Company Profile

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. It focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its portfolio includes ILUVIEN and NADPH Oxidase Inhibitors. The company was founded on June 4, 2003 by C. Daniel Myers and David R. Holland and is headquartered in Alpharetta, GA.